STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Initial Public Offering	Underwriters	Redeemable Convertible Preferred Stock	Common Stock	Common Stock Initial Public Offering	Common Stock Underwriters	Additional Paid-in Capital	Additional Paid-in Capital Initial Public Offering	Additional Paid-in Capital Underwriters	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balances at Dec. 31, 2020	$ (20,319)											$ (20,319)
Redeemable convertible preferred stock, Beginning balance at Dec. 31, 2020				$ 23,070
Redeemable convertible preferred stock, beginning balance, shares at Dec. 31, 2020				6,076,196
Beginning balances, shares at Dec. 31, 2020					2,707,468
Issuance of Series B redeemable convertible preferred stock at $15.00 per share for cash, net of issuance costs of $266				$ 79,734
Issuance of Series B redeemable convertible preferred stock at $15.00 per share for cash, net of issuance costs of $266, shares				5,333,292
Issuance of common stock upon the exercise of stock options, shares					22,830
Vesting of early exercised stock options	19							$ 19
Stock-based compensation	974							974
Redeemable convertible preferred stock, Accretion to redemption value and cumulative dividends on preferred stock				$ 6,515
Accretion to redemption value and cumulative dividends on preferred stock	(6,515)							(993)				(5,522)
Unrealized loss on available-for-sale investments	(27)										$ (27)
Net loss	(21,543)	$ 21,500										(21,543)
Ending balances at Dec. 31, 2021	(47,411)										(27)	(47,384)
Redeemable convertible preferred stock, ending balance at Dec. 31, 2021	$ 109,319			$ 109,319
Redeemable convertible preferred stock, ending balance, shares at Dec. 31, 2021	11,409,488			11,409,488
Ending balances, shares at Dec. 31, 2021					2,730,298
Redeemable convertible preferred stock, conversion of convertible preferred stock into common stock				$ (111,139)
Redeemable convertible preferred stock, conversion of convertible preferred stock into common stock, shares				(11,409,488)
Issuance of common stock upon the exercise of stock options, shares	0
Issuance of common stock upon initial public offering, net of underwriters' commission and offering costs		60,836	$ 9,530						$ 60,836	$ 9,530
Issuance of common stock upon initial public offering, net of underwriters' commission and offering costs, shares						4,600,000	690,000
Vesting of early exercised stock options	$ 21							21
Repurchase of early exercised stock options	(11)							(11)
Repurchase of early exercised stock options, shares					(27,128)
Stock-based compensation	4,391							4,391
Redeemable convertible preferred stock, Accretion to redemption value and cumulative dividends on preferred stock				$ 1,820
Accretion to redemption value and cumulative dividends on preferred stock	(1,820)							(437)				(1,383)
Conversion of convertible preferred stock into common stock	111,139							111,139
Conversion of convertible preferred stock into common stock, shares					11,409,488
Unrealized loss on available-for-sale investments	(347)										(347)
Net loss	(40,956)	$ 41,000										(40,956)
Ending balances at Dec. 31, 2022	95,372							$ 185,469			$ (374)	$ (89,723)
Redeemable convertible preferred stock, ending balance at Dec. 31, 2022
Redeemable convertible preferred stock, ending balance, shares at Dec. 31, 2022	0			0
Ending balances, shares at Dec. 31, 2022					19,402,658